The edematogenic properties of insulin.
The edematogenic properties of insulin have long been documented, although they have been underestimated despite current trends toward intensive insulin therapy. Insulin treatment has been associated with weight gain, mild or moderate edema, and, rarely, generalized edema and cardiopulmonary congestion. In addition, the use in recent years of thiazolidinediones, which improve insulin sensitivity, has been associated with weight gain and peripheral edema, which can progress to pulmonary edema, particularly when thiazolidinediones are used in combination with insulin. This article attempts to raise awareness about the overlooked edematogenic action of insulin. In addition, the potential role of edema-provoking properties of insulin in the development of vascular complications in patients with diabetes is discussed.
Kalambokis
Georgios N
GN
Department of Internal Medicine, Medical School of Ioannina, Medical School of Ioannina, Ioannina, Greece.
Tsatsoulis
Agathocles A
AA
Tsianos
Epameinondas V
EV
D002199:Capillary Permeability / Q000187:drug effects; D003925:Diabetic Angiopathies / Q000209:etiology / Q000503:physiopathology; D004347:Drug Interactions; D004487:Edema / Q000139:chemically induced* / Q000503:physiopathology; D006003:Glycogen / Q000378:metabolism; D006801:Humans; D006946:Hyperinsulinism / Q000503:physiopathology; D007004:Hypoglycemic Agents / Q000009:adverse effects*; D007328:Insulin / Q000009:adverse effects*; D008928:Mitochondria; D012964:Sodium / Q000378:metabolism; D045162:Thiazolidinediones / Q000009:adverse effects; D014882:Water-Electrolyte Balance / Q000187:drug effects; D015430:Weight Gain
D007004:Hypoglycemic Agents; D007328:Insulin; D045162:Thiazolidinediones; D006003:Glycogen; D012964:Sodium